Beta-glucan (oat and barley)
Also called: oat beta-glucan, barley beta-glucan, β-glucan, oat bran, oatrim, barley betafiber
A viscous, soluble fiber found in oats and barley. US rules recognize beta-glucan soluble fiber from oat bran, rolled oats, whole oat flour, oatrim, whole grain and dry milled barley, and barley betafiber. Health Canada lists yeast beta-glucan as a separate ingredient.
- Category
- Other
- Forms
- Oat and barley sources named in 21 CFR 101.81 (oat bran, rolled oats, whole oat flour, oatrim, whole grain and dry milled barley, barley betafiber); Health Canada lists oat and barley seed bran
- Strongest evidence
- A Strong
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2016 meta-analysis pooled 58 RCTs (3,974 participants) of diets enriched with oat beta-glucan versus control diets. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
AHeart and blood vessels2 topics
ABlood sugar and weight2 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| LDL cholesterol (oat beta-glucan) | A | A 2016 meta-analysis of 58 RCTs (3,974 participants; median 3.5 g/day, 3 weeks or longer) found oat beta-glucan lowered LDL cholesterol by 0.19 mmol/L, non-HDL cholesterol by 0.20 mmol/L and apoB by 0.03 g/L versus control. [2] |
| LDL cholesterol (barley beta-glucan) | A | A 2016 meta-analysis of 14 RCTs (615 participants; median 6.5–6.9 g/day for a median 4 weeks) found barley beta-glucan lowered LDL cholesterol by 0.25 mmol/L and non-HDL cholesterol by 0.31 mmol/L; apoB did not change significantly. [3] |
| Blood glucose and insulin after meals | A | A 2021 meta-analysis of 103 acute crossover trial comparisons (538 participants) found adding oat beta-glucan to carbohydrate meals reduced glucose response (iAUC) by 23% and insulin by 22%; certainty was high and effects depended on dose and molecular weight. [4] |
| Fasting glucose and HbA1c in type 2 diabetes | B | A 2016 meta-analysis of 4 articles (350 patients; 2.5–3.5 g/day for 3–8 weeks) found oat beta-glucan lowered fasting glucose by 0.52 mmol/L and HbA1c by 0.21%; fasting insulin did not fall significantly. [5] |
Main constituents: Beta (β) glucan soluble fiber, determined by AOAC method 992.28 for the US health claim [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- US health claim: 3 g or more per day of β-glucan soluble fiber from whole oats or barley, or a combination of whole oats and barley. [1]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Canada (Health Canada Beta-Glucan monograph, July 31, 2026), adults 18 years and older: oat and/or barley beta-glucan 2–10 g per day.
Details and sources
- Health Canada's beta-glucan monograph requires no contraindication and no known-adverse-reaction statement for oat or barley beta-glucan products. [6]
Identity, quality and standardization
- For the US claim, oat bran must provide at least 5.5% (dry weight basis) β-glucan soluble fiber; rolled oats, whole oat flour and whole grain barley at least 4%; barley bran and sieved barley meal at least 5.5%; barley betafiber at least 70%; oatrim up to 10%. [1]
- In the postprandial-glucose meta-analysis, oat beta-glucan with molecular weight above 300 kg/mol significantly reduced glucose response, whereas molecular weight below 300 kg/mol did not. [4]
- Health Canada lists yeast beta-glucan (Saccharomyces cerevisiae cell wall, not less than 80% beta-1,3/1,6-glucan) separately from oat and barley beta-glucan, with different uses and doses. [6]
Regulatory status
- US: FDA authorizes a health claim (21 CFR 101.81). Model claim as eCFR states it: "Soluble fiber from foods such as [name of soluble fiber source from paragraph (c)(2)(ii) of this section and, if desired, the name of food product], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [ name of food] supplies ________ grams of the [grams of soluble fiber specified in paragraph (c)(2)(i)(G) of this section] soluble fiber from [name of the soluble fiber source from paragraph (c)(2)(ii) of this section] necessary per day to have this effect." [1]
- US: the claim must say such diets "may" or "might" reduce the risk of heart disease, must not attribute any degree of risk reduction, must state the 3 g daily intake and one serving's contribution, and is limited to foods that are low in saturated fat and cholesterol and contain at least 0.75 g soluble fiber per reference amount. [1]
- US: beta-glucan soluble fiber (as described in 101.81(c)(2)(ii)(A)) is one of seven isolated or synthetic non-digestible carbohydrates FDA determined meet its dietary fiber definition (May 27, 2016 final rule). [7]
- Canada: Health Canada's beta-glucan monograph (July 31, 2026) permits oat and/or barley beta-glucan claims for lowering LDL cholesterol and for postprandial glucose metabolism. [6]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Beta-glucan, a viscous soluble fiber of oats and barley Polysaccharides (soluble fiber) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming oat or barley beta-glucan was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29); the list's 4 beta-glucan entries name Aureobasidium pullulans culture or Euglena gracilis sources. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
- 21 CFR 101.81 authorizes a health claim for β-glucan soluble fiber from whole oats or barley (3 g or more per day) and reduced risk of coronary heart disease, for foods meeting its conditions. [P3]
- GRAS: FDA had no questions about GRAS Notices 437 (closed January 27, 2013) and 544 (closed May 5, 2015) for beta-glucans from oat bran. GRAS notices concern food uses. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of oat or barley beta-glucan was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P5]
- The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of oat or barley beta-glucan (checked 2026-10-29). [P6]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P7]
- β-glucan soluble fiber content by AOAC method 992.28 — Method FDA specifies for β-glucan soluble fiber under the 101.81 health claim; eligible oat and barley sources must meet minimum β-glucan and total dietary fiber contents. [P3]
- Molecular weight of oat beta-glucan — A 2021 meta-analysis found oat beta-glucan above 300 kg/mol reduced postprandial glucose while beta-glucan below 300 kg/mol did not. [P8]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Canada (Health Canada Beta-Glucan monograph, July 31, 2026), adults 18 years and older: oat and/or barley beta-glucan 2–10 g per day. [P9]
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Ho HV, et al. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 2016;116(8):1369-1382 (PMID 27724985), 2016-10. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 101.81, Health claims: Soluble fiber from certain foods and risk of coronary heart disease (CHD) (up to date as of 10/28/2026), 2026-10-28. ecfr.gov
- FDA. GRAS Notice Inventory (downloaded export; inventory last updated 10/21/2026; downloaded 10/29/2026), 2026-10-21. hfpappexternal.fda.gov
- IARC Monographs. List of Classifications, Volumes 1–142 (list data dated 2026-07-23; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/28/2026), 2026-10-28. ecfr.gov
- Zurbau A, et al. The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. Eur J Clin Nutr 2021;75(11):1540-1554 (PMID 33608654), 2021-11. pubmed.ncbi.nlm.nih.gov
- Health Canada NNHPD. Natural health product monograph: Beta-Glucan (date July 31, 2026), 2026-07-31. webprod.hc-sc.gc.ca
Sources
- eCFR. 21 CFR 101.81, Health claims: Soluble fiber from certain foods and risk of coronary heart disease (CHD) (up to date as of 10/28/2026), 2026-10-28. ecfr.gov
- Ho HV, et al. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 2016;116(8):1369-1382 (PMID 27724985), 2016-10. pubmed.ncbi.nlm.nih.gov
- Ho HV, et al. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction. Eur J Clin Nutr 2016;70(11):1239-1245 (PMID 27273067), 2016-11. pubmed.ncbi.nlm.nih.gov
- Zurbau A, et al. The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. Eur J Clin Nutr 2021;75(11):1540-1554 (PMID 33608654), 2021-11. pubmed.ncbi.nlm.nih.gov
- Shen XL, et al. Effect of oat β-glucan intake on glycaemic control and insulin sensitivity of diabetic patients: a meta-analysis of randomized controlled trials. Nutrients 2016;8(1) (PMID 26771637), 2016-01. pubmed.ncbi.nlm.nih.gov
- Health Canada NNHPD. Natural health product monograph: Beta-Glucan (date July 31, 2026), 2026-07-31. webprod.hc-sc.gc.ca
- FDA. Questions and Answers on Dietary Fiber (content current as of 07/25/2024), 2024-07-25. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Betaine (trimethylglycine) · Bromelain · Caffeine · Choline · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.